UK markets open in 4 hours 6 minutes

Shield Therapeutics plc (STX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
6.00+0.20 (+3.45%)
At close: 05:07PM GMT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
6,187
4,467
1,519
10,387
719
Cost of revenue
3,416
2,470
980
1,354
485
Gross profit
2,771
1,997
539
9,033
234
Operating expenses
Research development
193
1,072
579
2,579
2,496
Selling general and administrative
28,268
27,331
20,023
5,903
4,152
Total operating expenses
24,976
27,703
20,491
11,187
9,269
Operating income or loss
-22,205
-25,706
-19,952
-2,154
-9,035
Interest expense
905
389
8
0
49
Income before tax
-37,213
-40,082
-19,565
-1,886
-9,066
Income tax expense
718
362
-229
744
-266
Income from continuing operations
-37,931
-40,444
-19,336
-2,630
-8,800
Net income
-37,931
-40,444
-19,336
-2,630
-8,800
Net income available to common shareholders
-37,931
-40,444
-19,336
-2,630
-8,800
Basic EPS
-0.12
-0.17
-0.10
-0.02
-0.08
Diluted EPS
-0.12
-0.17
-0.10
-0.02
-0.08
Basic average shares
476,634
237,906
204,409
120,682
120,428
Diluted average shares
476,634
237,906
204,409
120,682
120,428